FEDERAL LOBBYING RECORDS
LOBBYING FILINGS AND MARKET CONTEXT
Indexed federal lobbying filings mapped to clients, registrants, and public-company tickers. Transaction dates are compared with filing periods to identify date-proximity review flags. Proximity does not establish coordination, influence, or wrongdoing.
Filings tracked
20,641
thru 2026-07-15
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,260
paying companies
Tickers targeted
1,219
public companies
Clients by reported amount
| # | Client | Filings | Total $ |
|---|---|---|---|
| 1 |  PFIZER INC.PFE | 48 | $46.9M |
| 2 |  GENERAL MOTORS COMPANYGM | 61 | $46.8M |
| 3 |  META PLATFORMS INC. AND VARIOUS SUBSIDIARIESMETA | 13 | $45.0M |
| 4 | VISA INC.V | 46 | $37.7M |
| 5 |  AMAZON.COM SERVICES LLCAMZN | 37 | $32.8M |
| 6 |  LOCKHEED MARTIN CORPORATIONLMT | 76 | $29.1M |
| 7 |  FEDEX CORPORATIONFDXW | 71 | $27.9M |
| 8 |  ELI LILLY AND COMPANYLLY | 60 | $27.4M |
| 9 |  ALTRIA CLIENT SERVICES LLCMO | 147 | $25.3M |
| 10 |  COMCAST CORPORATIONCMCSV | 183 | $24.9M |
| 11 |  AMGEN INCAMGN | 19 | $24.9M |
| 12 |  MERCK & CO INCMRK | 14 | $24.0M |
| 13 |  SOUTHERN COMPANYSO | 54 | $23.9M |
| 14 |  GOOGLE CLIENT SERVICES LLCGOOGL | 83 | $22.8M |
| 15 |  APPLE INCAAPL | 9 | $22.1M |
| 16 |  T-MOBILE USA INC.TMUS | 131 | $21.3M |
| 17 |  UNITEDHEALTH GROUP INCUNH | 19 | $20.4M |
| 18 |  VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIESVZ | 41 | $20.1M |
| 19 |  OCCIDENTAL PETROLEUM CORPORATIONOXY | 32 | $19.8M |
| 20 |  MICROSOFT CORPORATIONMSFT | 107 | $18.9M |
| 21 |  QUALCOMM INCORPORATEDQCOM | 40 | $17.2M |
| 22 |  BOEING COMPANYBA | 24 | $17.0M |
| 23 |  GENERAL DYNAMICS CORPGD | 11 | $17.0M |
| 24 | THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)CI | 13 | $16.9M |
| 25 |  ORACLE CORPORATIONORCL | 60 | $16.8M |
Mapped tickers by reported amount
| # | Ticker | Filings | Total $ |
|---|---|---|---|
| 1 | META Meta Platforms Inc. | 134 | $50.3M |
| 2 | PFE Pfizer Inc. | 89 | $48.7M |
| 3 | GM General Motors Company | 103 | $48.4M |
| 4 | V Visa Inc. | 47 | $37.7M |
| 5 | AMZN Amazon.com Inc. | 82 | $35.4M |
| 6 | LMT Lockheed Martin Corporation | 92 | $29.5M |
| 7 | FDX FedEx Corporation | 83 | $28.4M |
| 8 | LLY Eli Lilly and Company | 88 | $28.4M |
| 9 | AMGN Amgen Inc. | 100 | $28.0M |
| 10 | MRK Merck & Co. Inc. | 92 | $27.5M |
| 11 | AAPL Apple Inc. | 66 | $27.0M |
| 12 | GOOGL Alphabet Inc. Class A | 128 | $26.8M |
| 13 | MO | 172 | $26.4M |
| 14 | SO Southern Company | 110 | $26.2M |
| 15 | UNH UnitedHealth Group Inc. | 68 | $24.0M |
| 16 | VZ Verizon Communications Inc. | 119 | $23.8M |
| 17 | TMUS | 170 | $22.9M |
| 18 |  CHTR | 142 | $22.8M |
| 19 | GD General Dynamics Corporation | 131 | $22.6M |
| 20 |  TAT&T Inc. | 137 | $21.7M |
| 21 | ORCL Oracle Corporation | 135 | $20.8M |
| 22 | CMCSA Comcast Corporation | 142 | $20.5M |
| 23 | OXY Occidental Petroleum Corporation | 38 | $20.1M |
| 24 | CI The Cigna Group | 64 | $19.9M |
| 25 | MSFT Microsoft Corporation | 126 | $19.3M |
🆕 Filtered Filings · CVS HEALTH
clear filters| Date | Ticker | Client | Registrant | Amount | Issue |
|---|---|---|---|---|---|
| 2026-07-15 | CVS | CVS HEALTH | KOUNTOUPES DENHAM CARR & REID, LLC | $60K | Issues related to pharmaceutical supply chains and patient access. Issues related to Medicare Part D, Medicare Advantage and Medicaid. |
| 2026-04-20 | CVS | CVS HEALTH | MICHAEL BEST STRATEGIES LLC | $40K | Issues related to retail pharmacies, insurance, and Medicare/Medicaid. Issues related to retail pharmacies, insurance, and Medicare/Medicaid. Issues related to retail pharmacies, insurance, and Medicare/Medicaid. Issues related to retail pharmacies, insurance, and Medicare/Medicaid. |
| 2026-04-20 | CVS | CVS HEALTH | ALSTON & BIRD LLP | $30K | Issues related to Pub. L. No. 119-21, One Big Beautiful Bill Act, PBM reform and drug pricing. |
| 2026-04-17 | CVS | CVS HEALTH | CONTINENTAL STRATEGY, LLC | $105K | facilitated meetings and discussions regarding the healthcare industry. |
| 2026-04-15 | CVS | CVS HEALTH | KOUNTOUPES DENHAM CARR & REID, LLC | $60K | Issues related to pharmaceutical supply chains and patient access. Issues related to Medicare Part D, Medicare Advantage and Medicaid. |
| 2026-04-09 | CVS | CVS HEALTH | KLEIN/JOHNSON GROUP | $0 | |
| 2026-03-30 | CVS | CVS HEALTH | MICHAEL BEST STRATEGIES LLC | $0 | Issues related to retail pharmacies, insurance, and Medicare/Medicaid. Issues related to retail pharmacies, insurance, and Medicare/Medicaid. Issues related to retail pharmacies, insurance, and Medicare/Medicaid. Issues related to retail pharmacies, insurance, and Medicare/Medicaid. |
| 2026-01-20 | CVS | CVS HEALTH | KLEIN/JOHNSON GROUP | $50K | Issues related to CVS Healths acquisition of Aetna; Issues related to competition and consumer protection in pharmaceutical supply chain. General education about the pharmacy benefit manager/pharmacy and insurance industry; issues related to PBMs, including insulin. Issues related to organized retail crime enforcement |
| 2026-01-20 | CVS | CVS HEALTH | ALSTON & BIRD LLP | $30K | Issues related to Pub. L. No. 119-21, One Big Beautiful Bill Act, PBM reform and drug pricing. |
| 2026-01-19 | CVS | CVS HEALTH | CONTINENTAL STRATEGY, LLC | $105K | facilitated meetings and discussions regarding the healthcare industry. |
| 2026-01-15 | CVS | CVS HEALTH | KOUNTOUPES DENHAM CARR & REID, LLC | $60K | Issues related to pharmaceutical supply chains and patient access. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to Medicare Part D, Medicare Advantage and Medicaid. |
| 2026-01-15 | CVS | CVS HEALTH | KEEFE SINGISER PARTNERS, FKA KEEFE STRATEGIES LLC | $30K | Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery. Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs. |
| 2026-01-15 | CVS | CVS HEALTH | KEEFE STRATEGIES LLC (FKA KEEFE SINGISER PARTNERS) | $0 | Lowering the cost of health care and prescription drug prices, quality health care, patient outcomes, health care delivery, smoking cessation, and women's heart health. Lowering the cost of health care and prescription drug prices, quality health care, patient outcomes, health care delivery, smoking cessation, and women's heart health. |
| 2025-10-20 | CVS | CVS HEALTH | CONTINENTAL STRATEGY, LLC | $105K | facilitated meetings and discussions regarding the healthcare industry. |
| 2025-10-20 | CVS | CVS HEALTH | KLEIN/JOHNSON GROUP | $50K | Issues related to CVS Healths acquisition of Aetna; Issues related to competition and consumer protection in pharmaceutical supply chain. General education about the pharmacy benefit manager/pharmacy and insurance industry; issues related to PBMs, including insulin. Issues related to organized retail crime enforcement |
| 2025-10-20 | CVS | CVS HEALTH | ALSTON & BIRD LLP | $30K | Issues related to Pub. L. No. 119-21, One Big Beautiful Bill Act, PBM reform and drug pricing. |
| 2025-10-15 | CVS | CVS HEALTH | KEEFE SINGISER PARTNERS, FKA KEEFE STRATEGIES LLC | $30K | Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery. Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs. |
| 2025-10-14 | CVS | CVS HEALTH | KOUNTOUPES DENHAM CARR & REID, LLC | $60K | Issues related to pharmaceutical supply chains and patient access. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to Medicare Part D, Medicare Advantage and Medicaid. Issues related to employer, small group, and individual insurance markets. Issues related to telehealth and remote patient monitoring. |
| 2025-07-21 | CVS | CVS HEALTH | KLEIN/JOHNSON GROUP | $50K | Issues related to CVS Healths acquisition of Aetna; Issues related to competition and consumer protection in pharmaceutical supply chain. General education about the pharmacy benefit manager/pharmacy and insurance industry; issues related to PBMs, including insulin. Issues related to organized retail crime enforcement |
| 2025-07-21 | CVS | CVS HEALTH | ALSTON & BIRD LLP | $40K | Issues related to the implementation of health care reform and issues related to PBMs and drug pricing. |
| 2025-07-18 | CVS | CVS HEALTH | CONTINENTAL STRATEGY, LLC | $105K | facilitated meetings and discussions regarding the healthcare industry. |
| 2025-07-18 | CVS | CVS HEALTH | KEEFE SINGISER PARTNERS, FKA KEEFE STRATEGIES LLC | $25K | Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery. Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs. |
| 2025-07-16 | CVS | CVS HEALTH | KOUNTOUPES DENHAM CARR & REID, LLC | $60K | Issues related to pharmaceutical supply chains and patient access. Issues related to Medicare Part D, Medicare Advantage and Medicaid. Issues related to employer, small group, and individual insurance markets. Issues related to telehealth and remote patient monitoring. |
| 2025-05-07 | CVS | CVS HEALTH | CONTINENTAL STRATEGY, LLC | $50K | facilitated meetings and discussions regarding the healthcare industry. |
| 2025-04-24 | CVS | CVS HEALTH | CONTINENTAL STRATEGY, LLC | $0 | monitor legislation and regulatory developments and facilitate meetings and discussions regarding the healthcare industry. |
| 2025-04-21 | CVS | CVS HEALTH | KLEIN/JOHNSON GROUP | $50K | Issues related to CVS Healths acquisition of Aetna; Issues related to competition and consumer protection in pharmaceutical supply chain. General education about the pharmacy benefit manager/pharmacy and insurance industry; issues related to PBMs, including insulin. Issues related to organized retail crime enforcement |
| 2025-04-21 | CVS | CVS HEALTH | ALSTON & BIRD LLP | $30K | Issues related to the implementation of health care reform and issues related to PBMs and drug pricing. |
| 2025-04-14 | CVS | CVS HEALTH | KOUNTOUPES DENHAM CARR & REID, LLC | $60K | Issues related to pharmaceutical supply chains. Issues related to Medicare Part D, Medicare Advantage and Medicaid. Issues related to employer, small group, and individual insurance markets. |
| 2025-04-10 | CVS | CVS HEALTH | KEEFE SINGISER PARTNERS, FKA KEEFE STRATEGIES LLC | $25K | Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery. Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs. |
| 2025-01-21 | CVS | CVS HEALTH | KLEIN/JOHNSON GROUP | $70K | Issues related to CVS Healths acquisition of Aetna; Issues related to competition and consumer protection in pharmaceutical supply chain. General education about the pharmacy benefit manager/pharmacy and insurance industry; issues related to PBMs, including insulin. Issues related to organized retail crime enforcement. |
| 2025-01-21 | CVS | CVS HEALTH | ALSTON & BIRD LLP | $70K | Issues related to the implementation of health care reform and issues related to PBMs and drug pricing. |
| 2025-01-20 | CVS | CVS HEALTH | KEEFE SINGISER PARTNERS, FKA KEEFE STRATEGIES LLC | $15K | Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery. Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs. |